The family of vascular endothelial growth factors (VEGFs) and their specific receptors (VEGFRs) are frequently targeted in cancer therapy, e.g., in lung, breast, kidney, ovarian and cervix cancer. This evidence concerns the gene VEGFA and cervical cancer.